Independent ETF Research for E*TRADE Investors

E*TRADE (now Morgan Stanley) gives you screeners, model portfolios, and education. Cognitor adds a conflict-light research stack: six independent specialists, five SENIOR verdicts, and one PRIME synthesis — with no Morgan Stanley ETF to sell you.

E*TRADE → Cognitor → YouExecution stays at E*TRADE. Research: six Panel lenses, five SENIOR verdicts, PRIME — each week the methodology assesses the macro scenario against the same ~40 curated US-listed ETFs, then the dossier deep-dives those selected for that edition (theses, validations, invalidations)—not a full standalone report on every ticker every Friday.

The E*TRADE research gap

E*TRADE offers screeners, pre-built Core Portfolio model allocations, and education. It does not produce six independent specialist lenses — each analyzing macro, geopolitics, tech cycles, emerging markets, fundamentals, and market psychology on the same ETFs without seeing the others' drafts — plus five SENIOR verdict pipelines and a PRIME synthesis that maps consensus, splits, and risk flags week to week.
  • Post-merger with Morgan Stanley, E*TRADE's research shelf includes house content; Cognitor has no fund family and no distribution incentives — the analysis is independent of any issuer.
  • E*TRADE's sector and thematic ETF screener helps you browse candidates; Cognitor's six-lens Panel helps you evaluate the macro and valuation case for the candidates you find.
  • For E*TRADE IRA and Roth IRA holders: Cognitor's macro and valuation context provides structured due diligence before annual or threshold-triggered rebalancing — without touching ERISA advice territory.
Validation mindset — structured research next to your brokerage execution

ETFs in the Cognitor universe

The fixed universe is ~40 curated US-listed ETFs—not the whole market. Each weekly dossier focuses on the subset selected for that week's scenario (deep research with theses, validations, and invalidations). The Panel still grounds the process in the full universe scan. Below are examples E*TRADE investors often hold or can map from their menu; each card opens that ticker's overview page. Inclusion is informational, not a buy or sell recommendation.

E*TRADE investors often use a mix of commission-free ETFs, Morgan Stanley model portfolios, and individual securities. Cognitor covers the US-listed ETF layer of that mix weekly. For taxable E*TRADE accounts, the research journal Cognitor enables is also useful for documenting the basis of allocation decisions.

How it fits your workflow

  1. Step 1Shortlist in E*TRADE screeners; confirm each ticker is one Cognitor covers weekly if you want the full Panel stack.
  2. Step 2Read the Friday pack for the holdings you actually size — especially before adding sector or thematic exposure.
  3. Step 3Log why you traded — useful for taxable accounts, wash-sale awareness, and future accountability.
Research at Cognitor, execution at your broker — connected workflow

Start free. Upgrade when it matters.

Free tier follows the same cadence with delays; Pro unlocks same-week dossiers, briefings, and Mon–Thu daily podcasts. About US$ 4.95/month with the current offer after a 7-day trial (list price US$ 9.90).

Free

$0

  • Full dossier on a 7-day delay; briefings after 24h vs Pro same-day
  • Great way to explore the Panel → SENIOR → PRIME workflow
Create free account

Pro

7-day trialMost popular

US$9.90 / month

US$4.95 / month

  • Weekly dossier deep-diving the ETFs selected for that week from ~40 US-listed names
  • Same-week briefings and Mon–Thu daily podcasts
  • Cancel anytime
Start Pro trial

Full plan comparison →

Transparency — research layer only; execution and custody stay at your broker

Common questions

US broker pages: how Cognitor complements E*TRADE without custody or order flow.

  • No. Cognitor is fully independent research software. Execution and custody remain at your E*TRADE account. Cognitor has no relationship with Morgan Stanley, E*TRADE Financial LLC, or any affiliated entity.